financetom
Business
financetom
/
Business
/
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 bln deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 bln deal
Jul 12, 2024 4:34 AM

July 12 (Reuters) - Top U.S. independent oil producer

ConocoPhillips ( COP ) said on Friday it received a second

request from the U.S. Federal Trade Commission for information

on its proposed acquisition of rival Marathon Oil ( MRO ).

ConocoPhillips ( COP ) said both companies received the requests on

July 11 and are working with the FTC to review the merger.

CONTEXT

Conoco said in May it would pay $22.5 billion in stock for

Marathon Oil ( MRO ) to boost its output and achieve greater economies

of scale in U.S. shale fields and in liquefied natural gas.

Its deal followed Exxon Mobil's ( XOM ) $60 billion

acquisition of Pioneer Natural Resources, Chevron's ( CVX )

proposed $53 billion merger with Hess, Chesapeake Energy's ( CHK )

$7.4 billion purchase of Southwestern Energy and

Occidental Petroleum's ( OXY ) $12 billion bid for CrownRock.

WHY IT'S IMPORTANT

The request for additional information is likely to slow the

closing of the deal. ConocoPhillips ( COP ) had said in May a

"conservative" estimate of when the deal will close is the

fourth quarter of this year, putting off a full realization of

the expected cost savings and benefits from shared equipment and

staff. It reiterated the timeframe on Friday.

The two companies have operations in West Texas, South Texas

and North Dakota's shale fields.

BY THE NUMBERS

The Conoco-Marathon combination would create a company

pumping 2.26 million barrels of oil and gas per day, and add

1.32 billion barrels of proved reserves to ConocoPhillips' ( COP ) 6.8

billion.

The offer of 0.255 shares of ConocoPhillips ( COP ) for each share

of Marathon represented a 14.7% premium to the company's

pre-deal closing price.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JPMorgan profit jumps on higher investment banking fees, accounting gain
JPMorgan profit jumps on higher investment banking fees, accounting gain
Jul 12, 2024
(Reuters) - JPMorgan Chase's ( JPM ) profit rose in the second quarter, buoyed by rising investment banking fees and an $8 billion accounting gain from a share exchange deal with Visa. Investment banks have benefited from a resurgence in capital-raising activity both in debt and equities markets. Wall Street banks are also seeing an uptick in fee income from...
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 billion deal
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 billion deal
Jul 12, 2024
(Reuters) - Top U.S. independent oil producer ConocoPhillips ( COP ) said on Friday it received a second request from the U.S. Federal Trade Commission for information on its proposed acquisition of rival Marathon Oil ( MRO ). ConocoPhillips ( COP ) said both companies received the requests on July 11 and are working with the FTC to review the...
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 bln deal
ConocoPhillips, Marathon Oil get second US FTC request over $22.5 bln deal
Jul 12, 2024
July 12 (Reuters) - Top U.S. independent oil producer ConocoPhillips ( COP ) said on Friday it received a second request from the U.S. Federal Trade Commission for information on its proposed acquisition of rival Marathon Oil ( MRO ). ConocoPhillips ( COP ) said both companies received the requests on July 11 and are working with the FTC to...
Novo Nordisk's Ozempic Reduces Dementia and Cognitive Risks, Oxford Study Says
Novo Nordisk's Ozempic Reduces Dementia and Cognitive Risks, Oxford Study Says
Jul 12, 2024
07:03 AM EDT, 07/12/2024 (MT Newswires) -- Novo Nordisk's ( NVO ) Ozempic may reduce the risk of dementia and other neurological issues compared to older antidiabetic medications like sitagliptin and glipizide, according to a study by the University of Oxford and published by The Lancet's eClinicalMedicine journal on Wednesday. After a year on Ozempic, patients showed a lower risk...
Copyright 2023-2026 - www.financetom.com All Rights Reserved